Chitra Sethi

Chitra Sethi, Managing Editor, BioPharm International

Articles

Spectrum Pharmaceuticals to Develop Biosimilar Rituximab

California-based biopharmceutical company Spectrum Pharmaceuticals will develop a biosimilar version of Swiss pharmaceutical giant Roche Holding AG's monoclonal antibody drug rituximab. Spectrum aims to achieve this through a partnership with Viropro Inc (Irvine, CA).

ATMI Acquires Artelis to Expand Portfolio of Single-Use Technology Products

ATMI, Inc. has acquired the Belgian biotechnology firm Artelis SA, which offers technologies for cell culture research and manufacturing scale-up.

Gilead Sciences Receives FDA Warning Letter

On September 21, 2010, Gilead Sciences (San Dimas, CA) received a warning letter from the US Food and Drug Administration, citing violations of current good manufacturing practices (cGMP) for its manufacturing and quality processes related to the production of antifungal agent AmBisome at its California facility.